CoChat

Complications, effectiveness, and long term follow‐up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection

Open access
van Beurden, Yvette H, de Groot, Pieter F, van Nood, Els, Nieuwdorp, Max, Keller, Josbert J, Goorhuis, Abraham · 2017 · United European Gastroenterology Journal
Cited by 76

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: Fecal microbiota transfer (FMT) is an effective treatment for recurrent Clostridium difficile infection (CDI), but data on procedure‐related complications and long‐term outcome are scarce. Methods: All patients treated with FMT for recurrent CDI at the Academic Medical Center between July 2010 and January 2016 were included. FMT was performed according to the FECAL trial protocol: administration of fresh donor feces (related or unrelated donor) through a duodenal tube after pre‐treatment with vancomycin and bowel lavage. We collected information on FMT‐related complications, recurrent CDI, and short‐ and long‐term adverse events by telephone interviews using a structured questionnaire at three months after FMT, and at the time of data collection of this study. Results: In total, 39 patients were treated with FMT. The primary cure rate (no recurrence ≤8 weeks after one infusion with donor feces) was 82% (32 of 39 patients). Of the seven patients with recurrent CDI after FMT, four were cured by antibiotic therapy alone (fidaxomicin in three patients, metronidazole in one patient) and three by repeat FMT. Peri‐procedural complications occurred in five patients, comprising fecal regurgitation or vomiting. One patient died one week post‐FMT due to pneumonia; a causal relation with FMT could not be excluded. The follow‐up period ranged between 3 and 68 months. No long‐term side effects were reported. Conclusions: Our data underline the efficacy of FMT as treatment for recurrent CDI. Importantly, it is possible to cure post‐FMT recurrences with antibiotic therapy alone. Peri‐procedural complications do occur and should be closely monitored to help identify high‐risk patients. To minimize the risk of complications, all FMT candidates should be evaluated to assess the most ideal delivery method.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2050640616678099

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 76

Metadata

Authors
van Beurden, Y. H., de Groot, P. F., van Nood, E., Nieuwdorp, M., Keller, J. J., & Goorhuis, A.
Venue
United European Gastroenterology Journal
Publisher
Wiley
Published
2017-10
Volume
5
Issue
6
Pages
868-879
ISSN
  • 2050-6406 (ISSN-L)
  • 2050-6414
OpenAlex
W2547815244
Cited by
76
References
9
FWCI
6.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Complications, effectiveness, and long term follow‐up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection. https://app.cochat.ai/papers/10.1177/2050640616678099
The paper
van Beurden, Y. H., de Groot, P. F., van Nood, E., Nieuwdorp, M., Keller, J. J., & Goorhuis, A. (2017). Complications, effectiveness, and long term follow‐up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection. United European Gastroenterology Journal. https://doi.org/10.1177/2050640616678099

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.